Co-Founder And Ceo
CurrentAnecare has created ANEclear, the only FDA approved, CE Marked commercially available technology that reverses the effects of inhaled anesthetics in the brain to quickly return brain function, breathing and consciousness after surgery; delivering a safer, lower cost recovery. The market for ANEclear is more than 60 million annual global surgeries under inhaled anesthetics with the focus on improving outcomes for the 12.5 million annual U.S. elderly surgical patients at risk for delirium / cognitive decline and airway complications, and 3.5 million children who are at risk for both delirium and post-operative nausea and vomiting.